ライフサイエンスコーパス: pelvic

1 ate multiparametric MRI and both cardiac and pelvic (15)O-H(2)O PET and (82)Rb PET were performed.

2 Pelvic (82)Rb PET was performed.

3 eased risk of LN involvement (LNI) underwent pelvic (99m)Tc-trofolastat SPECT/CT before radical prost

4 cluded early (7.8%) and delayed leak (2.0%), pelvic abscess (4.7%), anastomotic fistula (0.8%), chron

5 composite endpoint of early or delayed leak, pelvic abscess, anastomotic fistula, chronic sinus, or a

6 erative days, including anastomotic leakage, pelvic abscess, and peritonitis.

7 s urinary K(+), prevented the development of pelvic allodynia and inflammation seen in rats expressin

8 e performed in the head (n = 3499), although pelvic and abdominal MRI constituted 22.3% (n = 1536) of

9 We compared the findings on pelvic and breast ultrasonography and bone age versus th

10 was noted to have bilateral ovarian masses, pelvic and para-aortic lymphadenopathy, and a 4-cm oment

11 c performance of 18F-FDG-PET/CT in detecting pelvic and paraaortic lymph node metastasis.

12 Bimanual pelvic and rectovaginal examination, as well as radiogra

13 Fourteen months later, she developed severe pelvic and right flank pain.

14 ificant lower radiation dose to operators at pelvic and thorax level.

15 Secondary endpoints of vaginal, pelvic, and distant recurrence were analysed according t

16 cedure (hours) was significantly shorter for pelvic angioembolization [3.0 (4.4) vs 4.3 (3.6); P < 0.

17 on-to-procedure-time data were collected for pelvic angioembolization as a marker of patients requiri

18 Parenchymal density values (HU) and renal pelvic anterior-posterior (AP) diameters of all groups w

19 ethods For this retrospective study, abdomen-pelvic (AP) and chest-abdomen-pelvic (CAP) CT scans were

20 ght weight, lead-free shield placed over the pelvic area of patients to minimize operator radiation d

21 Congenital pelvic arteriovenous malformations (AVMs) are high-flow

22 The protective effect of DVF during L-TME on pelvic autonomic nerves and postoperative urogenital fun

23 aneurysm as an outflow vein of a right-sided pelvic AVM.

24 Development of pelvic AVMs in this region of high VEGF expression occur

25 -reported overall health; chronic abdominal, pelvic, back, and joint pain; chronic headaches or migra

26 had osteoid osteoma in lower extremities or pelvic bones, 73% had muscular atrophy.

27 iative treatment of patients with pathologic pelvic by using fluoroscopy and cone-beam CT needle guid

28 14 subjects (13 female, 1 male) with various pelvic cancers (11 cervical, 2 rectal, 1 endometrial).

29 el target for adjuvant therapy when treating pelvic cancers with radiation therapy.

30 ic radiotherapy is an important treatment of pelvic cancers.

31 study, abdomen-pelvic (AP) and chest-abdomen-pelvic (CAP) CT scans were performed with either a three

32 l vasculature intimately associated with the pelvic cartilaginous symphysis-a noncapsulated cartilage

33 evere gynecological infections (mastitis and pelvic cellulitis) occurring in the French national coho

34 nes suggest that systematic thoracoabdominal-pelvic computed tomography (TAP-CT) may be helpful.

35 tcomes than those who underwent abdominal or pelvic CT (P = .01).

36 ogical and hepato-renal parameters, abdomino-pelvic CT and a CT-guided biopsy.

37 ong 42 111 women who underwent abdominal and pelvic CT examinations in the study period, 2763 (6.6%;

38 Figure 2: Axial unenhanced pelvic CT image.

39 Abdominal and pelvic CT performed at presentation did not show any abn

40 onal database was searched for abdominal and pelvic CT studies performed between June 2003 and Decemb

41 oposterior pelvic radiography and unenhanced pelvic CT were performed to rule out sacroiliitis.

42 d to compare parenchymal densities and renal pelvic diameter differences with normal, acute urinary d

43 Uncontrolled pelvic disease was very rare.

44 ease pathway and 6 were implicated in benign pelvic disease.

45 technique pioneered to facilitate difficult pelvic dissections.

46 No significant differences were observed in pelvic dose using the 2 different shields ( P=0.183).

47 To assess the effect of pelvic drainage after rectal surgery for cancer.

48 anterior gluteals that maximizes control of pelvic drop during upright walking.

49 adducted hips, valgus knees, and swing-side pelvic drop.

50 ditional suite of genes with minor, additive pelvic effects, again like G. aculeatus.

51 pelvic loss maps to recurrent deletions of a pelvic enhancer of the Pitx1 gene.

52 antimicrobial peptide transcripts evident in pelvic epithelium in the mature, but not fetal, kidney.

53 on screening for gynecologic conditions with pelvic examination for conditions other than cervical ca

54 y rates resulting from an abnormal screening pelvic examination for ovarian cancer ranged from 5% to

55 Although the pelvic examination is a common part of the physical exam

56 mplication rate within 1 year of a screening pelvic examination with abnormal findings.

57 ablished through careful medical history and pelvic examination, including the cotton-swab test.

58 t women's health are often evaluated through pelvic examination.

59 , it is unclear whether performing screening pelvic examinations in asymptomatic women has a signific

60 and potential harms of performing screening pelvic examinations in asymptomatic, nonpregnant adult w

61 d data from 14 countries on patients who had pelvic exenteration for LARC between 2004 and 2014 were

62 n-making and practices regarding the role of pelvic exenteration for locally advanced primary rectal

63 Consecutive patients who underwent pelvic exenteration for nonrectal pelvic malignancy betw

64 Pelvic exenteration remains an important treatment in se

65 le functional outcomes can be achieved after pelvic exenteration with en bloc sciatic nerve resection

66 ite this, select cohorts of patients require pelvic exenteration.

67 in the urinary tract, thus allowing thorough pelvic exploration.

68 h closer to the renal capsule than the renal pelvic fat.

69 rity of gene expression between pectoral and pelvic fins has been documented in chondrichthyans, but

70 mesh fails biomechanically when used in the pelvic floor and materials with improved performance can

71 PARTICIPANTS: At 9 clinical sites in the US Pelvic Floor Disorders Network, 183 postmenopausal women

72 Colonic sensorimotor disturbances and pelvic floor dysfunction (such as defecatory disorders)

73 ymer meshes that were adopted for use in the pelvic floor for treatment of POP and SUI.

74 y of peripheral and central pain mechanisms, pelvic floor muscle and autonomic dysfunction, anxiety,

75 Behavioral and pelvic floor muscle therapy (included 1 preoperative and

76 h mixed urinary incontinence, behavioral and pelvic floor muscle therapy combined with midurethral sl

77 whether a group intervention that comprised pelvic floor muscle training, mobility exercises, and bl

78 treatment guidelines, a stepwise approach of pelvic floor physical therapy and cognitive behavioural

79 wound healing, thereby potentially enhancing pelvic floor recovery after reconstructive surgery for p

80 Ls) provide structural support to the female pelvic floor, and a loss of USL structural integrity or

81 than 2 hours (35.6% vs 16.4%; P < .001), and pelvic fractures (43.8% vs 21.4%; P < .001); patients wi

82 Anatomical reconstruction of pelvic fractures has been shown to affect functional out

83 ecutive patients with cancer with pathologic pelvic fractures managed with percutaneous FICS.

84 rs: low number of vertebrae posterior to the pelvic girdle (65-68); thoracolumbar synarcual extending

85 In contrast, reductions in the length of the pelvic girdle and pelvic spines resulted from directiona

86 isc; radials proximally fused to each other; pelvic girdle extremely small and strongly arched; dorsa

87 mbar synarcual extending backward beyond the pelvic girdle; tail extremely short not protruding from

88 example of repeated evolution is the loss of pelvic hindfins in stickleback fish (Gasterosteus aculea

89 Risk for pelvic, hip, humerus, radius, ulna, carpal, metacarpal,

90 ssed SNs during surgery, but with respect to pelvic hotspots, in most cases they are more probably re

91 d risk of hip (HR, 1.10; 99% CI, 1.06-1.14), pelvic (HR, 1.10; 99% CI, 1.02-1.19), spinal (HR, 1.18;

92 t) for spinal (HR, 2.09; 99% CI, 1.66-2.65), pelvic (HR, 1.66; 99% CI, 1.26-2.20), and hip (HR, 1.50;

93 the urinary tract, a potential advantage for pelvic imaging.

94 La Chapelle-aux-Saints 1 exhibits a pelvic incidence (and hence lumbar lordosis) similar to

95 Pelvic infection according to original strict criteria w

96 efits of antibiotic prophylaxis for reducing pelvic infection after miscarriage surgery.

97 complete a spontaneous abortion would reduce pelvic infection among women and adolescents in low-reso

98 tive on the basis of the outcome of cost per pelvic infection avoided within 2 weeks of surgery.

99 esholds of willingness-to-pay per additional pelvic infection avoided.

100 The risk of pelvic infection was 4.1% (68 of 1676 pregnancies) in th

101 Pelvic infection was broadly defined by the presence of

102 The definition of pelvic infection was changed before the unblinding of th

103 Pelvic infection was defined by the presence of two or m

104 The primary outcome was pelvic infection within 14 days after surgery.

105 158 (5%) of 3412 women developed pelvic infection within 2 weeks of surgery, of whom 68 (

106 not result in a significantly lower risk of pelvic infection, as defined by pragmatic broad criteria

107 ntibiotic prophylaxis may reduce the risk of pelvic infection, which is an important complication of

108 ectly related to IUC use (n = 7) comprised 3 pelvic inflammatory disease (PID) cases and 4 pregnancie

109 lence, incidence, and chlamydia-attributable pelvic inflammatory disease (PID) incidence, assuming st

110 We evaluated the risk of pelvic inflammatory disease (PID), ectopic pregnancy, an

111 In women, chlamydial infections may cause pelvic inflammatory disease (PID), ectopic pregnancy, an

112 n-for example, cervicitis, endometritis, and pelvic inflammatory disease (PID), including an associat

113 transmitted infections that may progress to pelvic inflammatory disease and infertility.

114 ection in women causes complications such as pelvic inflammatory disease and tubal factor infertility

115 a genitalium infections in women progress to pelvic inflammatory disease versus 14.4% (5.9-24.6%) of

116 with an increased risk of preterm delivery, pelvic inflammatory disease, and an increased risk of ac

117 ated with certain infectious agents, such as pelvic inflammatory disease, ectopic pregnancy and tubal

118 management, leading to complications such as pelvic inflammatory disease, infertility, and ectopic pr

119 Serious consequences of STIs include pelvic inflammatory disease, infertility, cancer, and AI

120 orrhea and chlamydia are important causes of pelvic inflammatory disease.

121 blockage of fallopian tubes, can result from pelvic inflammatory disease.

122 ascend to infect the endometrium, leading to pelvic inflammatory disease.

123 vate insurance, patients with severe head or pelvic injuries, and those who died during hospitalizati

124 nship between step width, hip adduction, and pelvic list during bipedalism by altering step widths an

125 ion, the origin of the human-like pattern of pelvic list remains unresolved.

126 ults show that altering either step width or pelvic list to mimic those of chimpanzees affects hip ad

127 m the evolution of the human-like pattern of pelvic list.

128 -assisted radical prostatectomy and extended pelvic LN dissection (ePLND) were included.

129 T before radical prostatectomy with extended pelvic LN dissection.

130 Repeated pelvic loss maps to recurrent deletions of a pelvic enha

131 bate about the effectiveness and toxicity of pelvic lymph node (PLN) irradiation for the treatment of

132 dding sentinel node biopsy (SNB) to extended pelvic lymph node dissection (ePLND) remains controversi

133 This was followed by extended pelvic lymph node dissection (ePLND).

134 T/CT findings with radical prostatectomy and pelvic lymph node dissection (PLND) histopathology findi

135 increased use of radical prostatectomy with pelvic lymph node dissection for primary management of h

136 ubsequent radical prostatectomy and extended pelvic lymph node dissection.

137 f the cervical stroma ( Fig 1 ), and without pelvic lymph node involvement.

138 When adjusted for age, stage, and histology, pelvic lymph node TLG, PALN TLG, and PALN SUV(max) were

139 local recurrence (CT, 18%, vs. PET/CT, 37%), pelvic lymph nodes (CT, 21%, vs. PET/CT, 44%), and dista

140 ation therapy (IMRT) to the prostate and the pelvic lymph nodes (PPLN-IMRT) with prostate-only IMRT (

141 negative predictive value, and accuracy for pelvic lymph nodes in initial staging compared with path

142 tients already had disease metastatic to the pelvic lymph nodes or showed evidence of distant metasta

143 (18)F-DCFPyL depicted more pelvic lymph nodes than did MRI (128 vs 23 nodes).

144 Pattern analysis showed that pelvic lymph nodes were the most common site of recurren

145 (TLG) were determined for the primary tumor, pelvic lymph nodes, and PALNs.

146 ectomy, bilateral salpingo-oophorectomy, and pelvic lymphadenectomy revealed International Federation

147 Sentinel-lymph-node mapping with complete pelvic lymphadenectomy was done in 340 patients and para

148 and sentinel-lymph-node mapping followed by pelvic lymphadenectomy with or without para-aortic lymph

149 Pelvic magnetic resonance imaging demonstrated a 9.9-cm

150 We performed pelvic magnetic resonance imaging to confirm fistula res

151 tudy enrolled subjects with pathology-proven pelvic malignancies.

152 underwent pelvic exenteration for nonrectal pelvic malignancy between 2006 and 2017 were identified

153 atients with advanced or recurrent nonrectal pelvic malignancy.

154 of the abdomen and pelvis showed an 11.6-cm pelvic mass, retroperitoneal lymphadenopathy, right hydr

155 sical examination demonstrated a fixed, firm pelvic mass; a computed tomography-guided biopsy confirm

156 A complex pelvic morphology has been discovered in the fossils of

157 uring bipedalism by altering step widths and pelvic motions in humans in ways that both mimic chimpan

158 The temporal events of COP and pelvic movement were not significantly different in all

159 However, COP and pelvic movement were significantly later in the diagonal

160 ecorded and analyzed as the onset of COP and pelvic movement, the COP displacement, and cocontraction

161 iated a step was identical with the COP then pelvic movement.

162 The center of pressure (COP), pelvic movements, and muscle activities were recorded an

163 In this study, pelvic MR examinations including an IVIM sequence were p

164 (18)F-FCH (91/91), pelvic MRI (88/91), and PSMA (31/91) (Australia) were al

165 er the addition of data from multiparametric pelvic MRI (mpMR) and whole-body MRI (wbMR) to the inter

166 In high-resource settings, pelvic MRI (to assess tumor size and central pelvic spre

167 FCH 73% [32/44] versus 33% [3/9] [P < 0.02], pelvic MRI 70% [32/46] versus 50% [2/4] [P was not signi

168 Pelvic MRI and CT images are interchangeable in retrospe

169 he pseudo-CT (pCT) image using dual-contrast pelvic MRI data.

170 extra-PF sites on (18)F-FCH were within the pelvic MRI field.

171 Pelvic MRI was requested to exclude an anatomic cause of

172 ultiparametric MRI (hereafter referred to as pelvic MRI) to identify men who will best benefit from S

173 ostate cancer was detected in 28% (25/88) by pelvic MRI, 32% (29/91) by (18)F-FCH, and 42% (13/31) by

174 PET/CT (hereafter referred to as PSMA), and pelvic multiparametric MRI (hereafter referred to as pel

175 d on histologic analysis and to compare with pelvic multiparametric MRI in men with biochemically rec

176 erwent (18)F-DCFPyL PET/CT imaging and 3.0-T pelvic multiparametric MRI.

177 The pelvic MXPD significantly reduces first operator radiati

178 oronary intervention (n=632) with or without pelvic MXPD.

179 was assessed in an ex vivo mouse colorectum pelvic nerve preparation where test compounds were appli

180 afferents from the bladder (primarily in the pelvic nerve) and the urethra (in the pudendal and pelvi

181 bladder, both dependent on activation of the pelvic nerve, as well as changes in ion channel expressi

182 ion through primary afferent pathways in the pelvic nerve, which contain dichotomized afferents, coul

183 nsitization through primary afferents in the pelvic nerve, which contain dichotomized afferents, coul

184 thelium, which depended on activation of the pelvic nerve.

185 nerve) and the urethra (in the pudendal and pelvic nerves) to maintain continence or initiate mictur

186 Pelvic nodal and extrapelvic metastatic disease on (68)G

187 The increased risk of pelvic nodal involvement in this cohort has led to the d

188 Conclusion: SLND of pelvic nodal metastases was often not complete according

189 Conclusion: SLND of pelvic nodal metastases was often not complete according

190 Overall, fluorescence-guided pelvic nodal surgery underestimated the number of SNs in

191 Overall, fluorescence-guided pelvic nodal surgery underestimated the number of SNs in

192 r >/= 2 years (nonmetastatic); prostate (+/- pelvic node) radiotherapy was encouraged for men without

193 , confined to prostate fossa 21.5% (56/260), pelvic nodes 26.2% (68/260), and distant disease 17.7% (

194 6) to the fossa only, 49.4% (92/186) fossa + pelvic nodes and 12.4% (23/186) nodes alone/SBRT.

195 ssa in 21.5% (56/260), showed disease in the pelvic nodes in 26.2% (68/260), and showed distant disea

196 the patient level; in the subanalysis of the pelvic nodes region (four [8%; 2-19] with (18)F-fluciclo

197 es enable delivery of increased radiation to pelvic nodes with acceptable levels of toxicity.

198 a only, 49.4% (92/186) to the fossa plus the pelvic nodes, and 12.4% (23/186) to the nodes alone or s

199 ent of stress urinary incontinence (SUI) and pelvic organ prolapse (POP) have produced highly variabl

200 tegrity or biomechanical function may induce pelvic organ prolapse (POP).

201 cells obtained from women with uterovaginal pelvic organ prolapse following vaginal hysterectomy.

202 genic organizer, fibulin-5 (FBLN5), leads to pelvic organ prolapse in mice.

203 with obstetrical trauma is a risk factor for pelvic organ prolapse later in life.

204 outcome was self-reported prolapse symptoms (Pelvic Organ Prolapse Symptom Score [POP-SS]) at 2 years

205 es in genital hiatus (GH) and development of pelvic organ prolapse using data from the Mothers' Outco

206 s has been implicated in the pathogenesis of pelvic organ prolapse.

207 nts and therapeutics interventions affecting pelvic organs, including the LUT.

208 B-PC group (32% versus 11%, P < 0.01) and of pelvic origin (5% versus 0.1%, P < 0.01) compared to uri

209 Chronic pelvic pain (CPP) affects a significant number of women

210 isciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network uses a novel integra

211 isciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network.

212 ligible participants were women with chronic pelvic pain (with or without dysmenorrhoea or dyspareuni

213 Chronic pelvic pain affects 2-24% of women worldwide and evidenc

214 d safety of gabapentin in women with chronic pelvic pain and no obvious pelvic pathology.

215 bel gabapentin for the management of chronic pelvic pain and no obvious pelvic pathology.

216 necological disorder, associated with severe pelvic pain and reduced fertility; however, its molecula

217 There is a mixed impact on pelvic pain and sexual function which requires careful c

218 of the patients after LVMR but new onset of pelvic pain appeared in 15%.

219 mechanisms underlying chronic abdominal and pelvic pain associated with functional and inflammatory

220 e in improving dysmenorrhea and nonmenstrual pelvic pain during a 6-month period in women with endome

221 with surgically confirmed endometriosis and pelvic pain enrolled in a double-blind, randomized, plac

222 include it in the differential diagnosis of pelvic pain in women of child-bearing age.

223 isorder that is associated with debilitating pelvic pain in women.

224 ith irregular or excessive uterine bleeding, pelvic pain or pressure, or infertility.

225 rcourse presented with complaints of intense pelvic pain radiating to the perineal area.

226 Urologic chronic pelvic pain syndrome (UCPPS), which encompasses intersti

227 ain syndrome and chronic prostatitis/chronic pelvic pain syndrome, is characterized by chronic pain i

228 Pelvic pain was reported to be improved in 47% of the pa

229 ntly lower pain scores in women with chronic pelvic pain, and was associated with higher rates of sid

230 y associated with severe, acute, and chronic pelvic pain.

231 th intermenstrual bleeding, dyspareunia, and pelvic pain.

232 oman presented with increasing abdominal and pelvic pain.

233 ctomy (PN) for chronic endometriosis-related pelvic pain.

234 rate to severe dysmenorrhea and non-cyclical pelvic pain.

235 orientation and management of patients with pelvic pain.

236 with vitamin D led to significant changes in pelvic pain; however, these were similar in magnitude to

237 raception to avoid pregnancy, and no obvious pelvic pathology at laparoscopy, which must have taken p

238 gement of chronic pelvic pain and no obvious pelvic pathology.

239 omen with chronic pelvic pain and no obvious pelvic pathology.

240 mesothelial cells (HPMCs) recovered from the pelvic peritoneum of women with endometriosis exhibit si

241 ns) outside the uterus, most commonly on the pelvic peritoneum.

242 of multiple leiomyomas in the abdominal and pelvic peritoneum.

243 We compared the effectiveness of pelvic physiotherapy (PPT) vs standard medical care (SMC

244 sed in sNCCs localized in the NoR and in the pelvic plexus.

245 e so-called Nerve of Remak [NoR]) and to the pelvic plexus.

246 nce ratio [PR], 1.47; 95% CI, 1.20 to 1.76), pelvic radiation >= 34 Gy (PR, 1.46; 95% CI, 1.01 to 2.1

247 Survivors exposed to cranial radiation, pelvic radiation >= 34 Gy, abdominal radiation > 40 Gy,

248 Abdominal and pelvic radiation almost always results in some dose deli

249 d a prescribed dose model with abdominal and pelvic radiation doses and an ovarian dose model with ov

250 Figure 1: Anteroposterior pelvic radiograph.

251 Hip and pelvic radiographs from 1118 studies were reviewed, and

252 ts seen on weight-bearing anterior-posterior pelvic radiographs from participants in the Osteoarthrit

253 ts on 7738 weight-bearing anterior-posterior pelvic radiographs).

254 Anteroposterior pelvic radiography and unenhanced pelvic CT were perform

255 djuvant chemotherapy and radiotherapy versus pelvic radiotherapy alone for women with high-risk endom

256 d by standard CRT with weekly cisplatin plus pelvic radiotherapy or to standard CRT alone.

257 nal OS among patients not receiving previous pelvic radiotherapy was 24.5 months versus 16.8 months (

258 ture of La Chapelle-aux-Saints 1 using a new pelvic reconstruction to infer lumbar lordosis, interart

259 the mesh material with some applications in pelvic reconstructive surgeries and the lack of appropri

260 bidity, requirement of advanced surgery, and pelvic recurrence after regrowth treatment.

261 9 [95% CI 0.06-15.90]; p=0.99), and isolated pelvic recurrence was the first site of recurrence in th

262 er radiation dose compared with no shield at pelvic region (42 uSv [14-98] in group 1, 13 uSv [5-27]

263 nd sparing of normal tissue; however, in the pelvic region it is anatomically difficult to avoid off-

264 ome, is characterized by chronic pain in the pelvic region or genitalia that is often accompanied by

265 but the operator radiation dose received at pelvic region still remains high.

266 s suggested a retroperitoneal sarcoma in the pelvic region with metastases to the liver.

267 eprocessed and cropped to include the entire pelvic region.

268 , additional sites were found, mainly in the pelvic region.

269 correlates to damaged fat reservoirs in the pelvic region.

270 ion can be performed during extended radical pelvic resections with morbidity and survival outcomes c

271 Of 713 radical pelvic resections, 68 patients (9.5%) had en bloc sciati

272 t and left para-aortic and common iliac) and pelvic (right and left external iliac and obturator) LN

273 A chest, abdominal, and pelvic scan were acquired at each time point.

274 Reduction in pelvic score, a categorical measure of pelvic structure,

275 r conversion included dense adhesions (34%), pelvic sepsis with fistulizing disease (26%), large infl

276 Recurrent disease with dense adhesions, pelvic sepsis with fistulizing disease, large inflammato

277 Primary endpoint was postoperative pelvic sepsis within 30 postoperative days, including an

278 Here, we infer the genetic basis of pelvic skeleton reduction in Gasterosteus doryssus, a Mi

279 tions in the length of the pelvic girdle and pelvic spines resulted from directional shifts of unimod

280 pelvic MRI (to assess tumor size and central pelvic spread) and torso fluorodeoxyglucose PET/CT (to a

281 e argued to have permitted both lordosis and pelvic stabilization during upright walking are not pres

282 isted of a list-mode acquisition at a single pelvic station.

283 on in pelvic score, a categorical measure of pelvic structure, resulted primarily from reciprocal fre

284 of patients of any age who had abdominal or pelvic surgery done using laparoscopic or open approache

285 tive patients who underwent extended radical pelvic surgery with en bloc resection of the sciatic or

286 issues for almost any types of abdominal and pelvic surgery, leading to adverse consequences.

287 1, 72 270 patients had an index abdominal or pelvic surgery, of whom 21 519 (29.8%) had laparoscopic

288 Location of pelvic tumor was the major inferior disease-specific pro

289 ngo-oophorectomy, appendectomy, resection of pelvic tumor, omentectomy, and low anterior resection wi

290 Advanced pelvic tumors involving the sciatic or femoral nerve hav

291 the diagnostic performance of transabdominal pelvic ultrasonography and bone age in identifying the o

292 Pelvic ultrasonography, ultrasonographic assessment of T

293 lder, diagnosed with a missed miscarriage by pelvic ultrasound scan in the first 14 weeks of pregnanc

294 al scarring, distortion of renal calyces and pelvic, ureteric strictures, stenosis, urinary outflow t

295 dronephrosis and failure to develop a patent pelvic-ureteric junction.

296 -resource settings, analogous modalities are pelvic US and chest radiography.

297 ls and Methods Female patients who underwent pelvic US with or without Doppler from January 2009 thro

298 Pelvic vestiges also showed left-side larger asymmetry.

299 tion generates left-side larger asymmetry of pelvic vestiges in extant, closely related Gasterosteus

300 onal SWMR and radiographs in anteroposterior pelvic view.